.webp)
67/100B67.290
USD
-0.26
(-0.38%)
Post Trading·68.800USD+1.510(+2.24%)
Last updated: · Delayed 15 min
Fair value63.11Plus+7%48Price 67.2994
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
Royalty Pharma cash flow statement 2017–2026What is a cash flow statement? The cash flow statement shows the cash that came into a company and went out over a period, split into operating, investing and financing activities.
In fiscal year 2025 Royalty Pharma spent 1.23B USD buying back its shares and paid 378.25M USD in dividends: 1.61B USD in all. That is 64% of its free cash flow.
Operating cash flow Free cash flow
Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.
| Fiscal year | TTM 30 Sept 2026 | FY2025 31 Dec 2025 | FY2024 31 Dec 2024 | FY2023 31 Dec 2023 | FY2022 31 Dec 2022 | FY2021 31 Dec 2021 | FY2020 31 Dec 2020 | FY2019 31 Dec 2019 | FY2018 31 Dec 2018 | FY2017 31 Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Net income | — | 1.32B | 1.33B | 1.70B | 230.06M | 1.24B | 1.70B | 2.46B | 1.52B | 1.34B |
Depreciation and amortization | — | 3.85M | 0.00 | 0.00 | 5.67M | 23.00M | 23.06M | 23.92M | 33.27M | 33.27M |
Stock-based compensation | — | 289.89M | 2.34M | 2.36M | 2.17M | 2.44M | 5.43M | 0.00 | 0.00 | 0.00 |
Change in working capital | 32.02M | -17.15M | 53.38M | 5.38M | 32.66M | -16.32M | 75.97M | -24.67M | -1.56B | -1.48B |
Change in receivables | -6.68M | -2.36M | -4.55M | -1.52M | -4.74M | -29.14M | -400.00K | 159.86M | 111.53M | -84.48M |
Change in inventory | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Change in payables | -30.94M | -13.93M | -2.29M | 6.24M | 2.29M | -4.59M | -766.00K | 6.50M | 1.35M | 0.00 |
Change in other working capital | 69.64M | -863.00K | 60.22M | 667.00K | 35.12M | 17.41M | 77.13M | -191.03M | -1.68B | -1.39B |
Other non-cash items | 2.44B | 889.04M | 1.38B | 1.28B | 1.87B | 767.22M | 228.22M | -793.43M | 1.63B | 1.52B |
Operating cash flowWhat is a cash flow statement? The cash flow statement shows the cash that came into a company and went out over a period, split into operating, investing and financing activities. | 2.96B | 2.49B | 2.77B | 2.99B | 2.14B | 2.02B | 2.03B | 1.67B | 1.62B | 1.42B |
Operating cash flow growth | +23.06% | -10.08% | -7.32% | +39.36% | +6.27% | -0.84% | +22.04% | +3.02% | +14.10% | — |
Capital expenditure | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisitions | — | -74.42M | -10.96M | -12.54M | -9.90M | -34.86M | -40.16M | -27.04M | -24.17M | -2.00M |
Purchases of investments | -1.15B | -1.93B | -2.74B | -2.12B | -2.57B | -3.59B | -3.94B | -2.75B | -422.40M | -2.30B |
Sales and maturities of investments | 79.25M | 566.50M | 118.36M | 25.83M | 1.55B | 1.78B | 1.20B | 875.07M | 750.00M | 600.00M |
Other investing | -767.90M | -175.11M | -49.32M | 29.44M | 0.00 | -18.08M | 15.08M | -250.00M | 0.00 | 115.00M |
Investing cash flow | -1.84B | -1.61B | -2.68B | -2.07B | -1.03B | -1.87B | -2.76B | -2.15B | 303.42M | -1.59B |
Debt issued (repaid) | — | 954.48M | 1.47B | -1.00B | 0.00 | 1.27B | 680.63M | -294.00M | -294.00M | 907.00M |
Shares issued | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.91B | 0.00 | 0.00 | 0.00 |
Share buybacksWhat are stock buybacks? A stock buyback is a company buying its own shares on the market. With fewer shares left, each remaining share owns a bigger part of the company. | -261.62M | -1.23B | -229.65M | -304.76M | 0.00 | 0.00 | 0.00 | -4.27M | 0.00 | 0.00 |
Dividends paid | -408.87M | -378.25M | -376.47M | -358.33M | -333.32M | -285.18M | -397.84M | -739.28M | -814.36M | -735.17M |
Other financing | -493.67M | -534.81M | -503.97M | -485.67M | -611.53M | -602.24M | -704.36M | -154.08M | -270.74M | -295.08M |
Financing cash flow | -1.54B | -1.19B | 361.15M | -2.15B | -944.86M | 385.11M | 1.49B | -1.19B | -1.38B | -123.25M |
Net change in cash | -425.27M | -310.33M | 452.02M | -1.23B | 169.70M | 532.37M | 762.48M | -1.68B | 542.64M | -292.65M |
Free cash flowWhat is free cash flow (FCF)? Free cash flow is the cash a company's operations bring in minus what it spends on long-term assets (capex): cash left for debt, dividends and buybacks. | 2.96B | 2.49B | 2.77B | 2.99B | 2.14B | 2.02B | 2.03B | 1.67B | 1.62B | 1.42B |
Free cash flow growth | +23.06% | -10.08% | -7.32% | +39.36% | +6.27% | -0.84% | +22.04% | +3.02% | +14.10% | — |
Free cash flow margin | 113.12% | 104.69% | 122.33% | 126.89% | 95.83% | 88.12% | 95.87% | 91.90% | 90.16% | 88.76% |
Free cash flow per share | 5.30 | 4.45 | 4.66 | 4.96 | 3.80 | 4.86 | 5.24 | 4.71 | 4.57 | 4.00 |
Free cash flow per share growth | +26.15% | -4.56% | -5.94% | +30.58% | -21.97% | -7.21% | +11.36% | +3.02% | +14.10% | — |
Income taxes paid | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter | Q3 FY2026 30 Sept 2026 | Q2 FY2026 30 Jun 2026 | Q1 FY2026 31 Mar 2026 | Q4 FY2025 31 Dec 2025 | Q3 FY2025 30 Sept 2025 | Q2 FY2025 30 Jun 2025 | Q1 FY2025 31 Mar 2025 | Q4 FY2024 31 Dec 2024 | Q3 FY2024 30 Sept 2024 | Q2 FY2024 30 Jun 2024 | Q1 FY2024 31 Mar 2024 | Q4 FY2023 31 Dec 2023 | Q3 FY2023 30 Sept 2023 | Q2 FY2023 30 Jun 2023 | Q1 FY2023 31 Mar 2023 | Q4 FY2022 31 Dec 2022 | Q3 FY2022 30 Sept 2022 | Q2 FY2022 30 Jun 2022 | Q1 FY2022 31 Mar 2022 | Q4 FY2021 31 Dec 2021 | Q3 FY2021 30 Sept 2021 | Q2 FY2021 30 Jun 2021 | Q1 FY2021 31 Mar 2021 | Q4 FY2020 31 Dec 2020 | Q3 FY2020 30 Sept 2020 | Q2 FY2020 30 Jun 2020 | Q1 FY2020 31 Mar 2020 | Q4 FY2019 31 Dec 2019 | Q3 FY2019 30 Sept 2019 | Q2 FY2019 30 Jun 2019 | Q1 FY2019 31 Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income | 0.00 | -294.69M | 294.69M | 355.91M | 444.21M | 90.64M | 433.43M | 334.35M | 806.36M | 194.38M | -4.27M | 717.59M | 122.08M | 351.34M | 509.09M | -610.03M | 220.41M | 491.60M | 128.08M | 53.67M | 221.80M | 806.76M | 158.98M | 366.63M | 624.25M | 601.98M | 109.10M | 0.00 | 0.00 | 178.77M | 396.09M |
Depreciation and amortization | 0.00 | 1.29M | 1.17M | 1.20M | 1.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.67M | 5.80M | 5.80M | 5.73M | 5.67M | 5.80M | 5.80M | 5.73M | 5.73M | 5.80M | 5.80M | 5.73M | 6.60M |
Stock-based compensation | 0.00 | 0.00 | 0.00 | 125.77M | 72.84M | 90.77M | 515.00K | 525.00K | 526.00K | 681.00K | 612.00K | 617.00K | 581.00K | 586.00K | 573.00K | 583.00K | 582.00K | 509.00K | 496.00K | 504.00K | 505.00K | 721.00K | 713.00K | 840.00K | 848.00K | 3.74M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Change in working capital | 818.69M | -1.67B | 835.18M | 48.51M | -50.88M | 49.69M | -64.48M | 51.52M | -18.72M | 50.08M | -29.50M | 47.91M | -37.02M | 37.63M | -43.14M | 24.95M | -30.98M | 78.41M | -39.71M | 46.04M | -62.97M | 33.58M | -32.97M | 30.72M | -4.93M | -525.00K | 50.70M | 0.00 | 0.00 | -434.67M | -382.37M |
Change in receivables | -4.46M | -3.61M | 1.81M | -415.00K | -1.16M | -3.96M | 3.17M | -2.06M | -1.32M | -1.35M | |||||||||||||||||||||
Change in inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||
Change in payables | -7.49M | 10.16M | -5.08M | -28.53M | 10.91M | -6.39M | 10.09M | -5.87M | 7.20M | -6.00K | |||||||||||||||||||||
Change in other working capital | 830.64M | -1.68B | 838.45M | 77.46M | -60.63M | 60.04M | -77.73M | 59.45M | -24.61M | 51.44M | |||||||||||||||||||||
Other non-cash items | -132.62M | 2.65B | -370.50M | 295.76M | 235.16M | 132.89M | 226.60M | 356.13M | -84.55M | 413.07M | 697.79M | 6.52M | 487.89M | 218.26M | 567.31M | 1.15B | 348.81M | 4.44M | 365.73M | 383.95M | 304.63M | -315.07M | 393.71M | 161.69M | -117.12M | -121.92M | 305.58M | 472.63M | 413.24M | 586.96M | 412.67M |
Operating cash flowWhat is a cash flow statement? The cash flow statement shows the cash that came into a company and went out over a period, split into operating, investing and financing activities. | 686.08M | 686.16M | 760.54M | 827.15M | 702.62M | 363.98M | 596.08M | 742.53M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M | 1.03B | 569.93M | 538.83M | 574.95M | 460.27M | 489.96M | 469.76M | 531.72M | 526.10M | 565.67M | 508.85M | 489.00M | 471.10M | 478.43M | 419.03M | 336.79M | 432.99M |
Operating cash flow growth | -2.35% | +88.51% | +27.59% | +11.40% | -0.14% | -44.70% | -10.32% | -3.90% | +22.68% | +8.29% | |||||||||||||||||||||
Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | -226.00K | -74.19M | 0.00 | 0.00 | 0.00 | -3.98M | -6.97M | -1.99M | -3.98M | -2.99M | -3.58M | 0.00 | -6.85M | 0.00 | -3.05M | -6.54M | -10.89M | -8.71M | -8.71M | -10.89M | 0.00 | -16.12M | -13.14M | -4.36M | -4.00M | -9.84M | -8.84M |
Purchases of investments | -292.22M | 50.00M | -22.50M | -887.69M | -961.87M | -76.11M | -5.48M | -496.42M | -1.21B | -946.63M | -86.08M | -1.00B | -451.13M | -60.45M | -601.71M | -361.06M | -1.63B | -297.10M | -276.02M | -665.45M | -1.48B | -420.94M | -1.03B | -1.42B | -1.19B | -475.33M | -853.23M | -233.99M | -772.81M | -148.52M | -1.21B |
Sales and maturities of investments | 5.76M | 31.19M | 4.70M | 37.60M | 2.88M | 2.88M | 523.14M | 12.59M | 2.88M | 101.46M | 1.44M | 1.44M | 0.00 | 0.00 | 24.39M | 775.81M | 212.58M | 266.92M | 290.23M | 120.34M | 646.66M | 573.90M | 435.41M | 593.68M | 273.59M | 231.40M | 104.61M | 213.02M | 161.54M | 0.00 | 150.00M |
Other investing | 791.00K | -720.97M | -50.00M | 2.28M | 905.00K | -164.56M | -13.74M | -21.76M | 11.49M | -44.02M | 4.97M | 2.62M | 4.46M | 0.00 | 22.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -18.08M | 0.00 | 0.00 | 0.00 | 15.08M | 0.00 | 0.00 | 0.00 | 0.00 | -250.00M |
Investing cash flow | -285.66M | -187.42M | -520.17M | -847.80M | -958.31M | -311.98M | 503.92M | -505.59M | -1.19B | -893.18M | -86.65M | -1.00B | -450.66M | -63.43M | -558.53M | 414.74M | -1.43B | -30.18M | 11.17M | -551.65M | -845.50M | 126.17M | -599.30M | -832.40M | -920.20M | -244.97M | -761.75M | -25.33M | -615.27M | -158.37M | -1.32B |
Debt issued (repaid) | -380.00M | 0.00 | 0.00 | 0.00 | 954.48M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.27B | 0.00 | 0.00 | 0.00 | -94.77M | -47.10M | 822.50M | -73.50M | -73.50M | -73.50M | -73.50M |
Shares issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -907.00K | -8.58M | 1.92B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share buybacksWhat are stock buybacks? A stock buyback is a company buying its own shares on the market. With fewer shares left, each remaining share owns a bigger part of the company. | -86.34M | -44.64M | -50.10M | -80.54M | -146.49M | -291.57M | -708.78M | -52.61M | -97.05M | -80.00M | 0.00 | -30.20M | -140.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.90M | -2.33M |
Dividends paid | -105.12M | -104.92M | -104.49M | -94.34M | -95.31M | -93.24M | -95.36M | -93.66M | -94.06M | -94.94M | -93.81M | -89.34M | -89.75M | -90.61M | -88.63M | -84.20M | -83.81M | -83.05M | -82.26M | -73.60M | -73.02M | -72.58M | -65.98M | -57.61M | -54.88M | -143.58M | -141.78M | -175.24M | -167.99M | -198.38M | -197.67M |
Other financing | -127.29M | -123.59M | -118.08M | -124.72M | -149.94M | -123.00M | -137.16M | -111.70M | -134.40M | 1.33B | -118.19M | -112.36M | -129.62M | -256.39M | -121.74M | -181.35M | -146.28M | -145.21M | -138.70M | -124.47M | -165.25M | -151.83M | -160.69M | -218.88M | -199.16M | -148.12M | -138.20M | -37.07M | -39.20M | -36.40M | -41.46M |
Financing cash flow | -698.74M | -273.15M | -272.67M | -299.60M | 562.74M | -507.81M | -941.30M | -257.96M | -325.51M | 1.16B | -212.00M | -231.89M | -1.36B | -347.00M | -210.37M | -265.55M | -230.09M | -228.25M | -220.97M | -198.07M | 1.03B | -224.42M | -226.67M | -277.39M | -357.39M | 1.58B | 542.52M | -285.80M | -280.69M | -310.18M | -314.96M |
Net change in cash | -298.33M | 225.61M | -32.30M | -320.25M | 307.04M | -455.81M | 158.69M | -21.03M | -814.59M | 921.64M | 365.99M | -459.44M | -1.24B | 197.39M | 264.94M | 719.12M | -1.12B | 316.52M | 250.47M | -259.76M | 658.53M | 433.47M | -299.87M | -544.12M | -768.74M | 1.82B | 251.87M | 167.29M | -476.93M | -131.66M | -1.20B |
Free cash flowWhat is free cash flow (FCF)? Free cash flow is the cash a company's operations bring in minus what it spends on long-term assets (capex): cash left for debt, dividends and buybacks. | 686.08M | 686.16M | 760.54M | 827.15M | 702.62M | 363.98M | 596.08M | 742.53M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M | 1.03B | 569.93M | 538.83M | 574.95M | 460.27M | 489.96M | 469.76M | 531.72M | 526.10M | 565.67M | 508.85M | 489.00M | 471.10M | 478.43M | 419.03M | 336.79M | 432.99M |
Free cash flow growth | -2.35% | +88.51% | +27.59% | +11.40% | -0.14% | -44.70% | -10.32% | -3.90% | +22.68% | +8.29% | |||||||||||||||||||||
Free cash flow margin | 99.43% | 101.78% | 120.61% | 132.98% | 115.32% | 62.90% | 104.90% | 125.08% | 124.60% | 122.51% | |||||||||||||||||||||
Free cash flow per share | 1.23 | 1.23 | 1.36 | 1.48 | 1.26 | 0.65 | 1.03 | 1.26 | 1.19 | 1.10 | 1.11 | 1.28 | 0.95 | 1.00 | 1.70 | 1.09 | 0.89 | 0.95 | 0.76 | 0.96 | 0.77 | 0.88 | 0.87 | 1.46 | 1.38 | 1.38 | 1.34 | 1.36 | 1.18 | 0.95 | 1.22 |
Free cash flow per share growth | -1.88% | +90.34% | +31.81% | +17.25% | +5.82% | -41.30% | -7.31% | -1.77% | +24.37% | +9.91% | |||||||||||||||||||||
Income taxes paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
Common questions about Royalty Pharma's cash flow
Source: Financial Modeling Prep